Curtis G. Wiltse

Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON)

Jay N. Cohn, Marc A. Pfeffer, Jean L. Rouleau et al. · European Journal of Heart Failure · 2003 · 380 citations

Medicine, Cardiology, Pharmacology +14

Efficacy of Duloxetine on Cognition, Depression, and Pain in Elderly Patients With Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled Trial

Joel Raskin, Curtis G. Wiltse, Alan P. Siegal et al. · American Journal of Psychiatry · 2007 · 330 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Duloxetine in the Treatment of Depression

D. Goldstein, Yili Lu, Michael J. Detke et al. · Journal of Clinical Psychopharmacology · 2004 · 316 citations

Medicine, Pharmacotherapy, Psychiatry +17

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Michael J. Detke, Curtis G. Wiltse, Craig Mallinckrodt et al. · European Neuropsychopharmacology · 2004 · 283 citations

Medicine, Pharmacotherapy, Psychiatry +16

Assumption Testing in Population Pharmacokinetic Models: Illustrated with an Analysis of Moxonidine Data from Congestive Heart Failure Patients

M. O. Karlsson, E. Niclas Jonsson, Curtis G. Wiltse et al. · Journal of Pharmacokinetics and Biopharmaceutics · 1998 · 150 citations

Pharmacy, Pharmacokinetics, Pharmacology +12